| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/18/2013 | CN102379820B Sodium gualenate aqueous solution |
| 09/18/2013 | CN102370686B Medicinal composition for treating chronic liver disease and application thereof |
| 09/18/2013 | CN102362986B Medicament for treating gastropathy |
| 09/18/2013 | CN102351911B Method for synthesizing anticancer compound Na4Bi2Mn2W20C6H84N4O105 |
| 09/18/2013 | CN102344447B Moxifloxacin hydrochloride monohydrate crystal form and preparation method thereof |
| 09/18/2013 | CN102336701B Carvedilol sulphate crystals, preparation method and application thereof in medicine |
| 09/18/2013 | CN102320956B Sodium ferulate composition freeze-dried powder injection and preparation method thereof |
| 09/18/2013 | CN102319217B Polysaccharide coated magnetic nano-particle and preparation method |
| 09/18/2013 | CN102302635B Traditional Chinese medicine for treating haemorrhoids, chilblain and pressure sore and preparation method thereof |
| 09/18/2013 | CN102302559B Medicament for treating respiratory system diseases and application thereof |
| 09/18/2013 | CN102295640B 3-heterocycle schiff base-5-fluorine-indole-2-ketone compounds, preparation method thereof and application thereof |
| 09/18/2013 | CN102295619B Febuxostat compound, preparation method and pharmaceutical composition thereof |
| 09/18/2013 | CN102271659B Liposome of irinotecan or its hydrochloride and preparation method thereof |
| 09/18/2013 | CN102260294B Binuclear platinum (II) complex or platinum (II) complex and application thereof |
| 09/18/2013 | CN102258725B Sophora alopecuroide vagina cleaning bacteriostatic lotion and preparation method thereof |
| 09/18/2013 | CN102250104B Camptothecin derivative, and its synthetic method and application |
| 09/18/2013 | CN102247356B Use of andrographolides, dehydrated andrographolides, new andrographolides and deoxidized andrographolides |
| 09/18/2013 | CN102225047B Enteric solid oral dosage form of bisphosphonate containing a chelating agent |
| 09/18/2013 | CN102199145B Compound for the treatment of gastrointestinal disease |
| 09/18/2013 | CN102188636B Bamboo shoot extract with function of improving anemia, preparation method thereof and compound preparation thereof |
| 09/18/2013 | CN102176920B Curcuminoids and its metabolites for the application in ocular diseases |
| 09/18/2013 | CN102174042B 免疫抑制剂化合物和组合物 Immunosuppressive compounds and compositions |
| 09/18/2013 | CN102123716B Compositions and methods for treating viral infections |
| 09/18/2013 | CN102091055B Calcium dobesilate capsule and preparation method thereof |
| 09/18/2013 | CN102060889B Stilbene glycoside derivative |
| 09/18/2013 | CN102060848B Preparation and application of aromatic amine substituted pyrimidine derivatives |
| 09/18/2013 | CN102050852B 2'-O-rhamnosyl swertisin, preparation of analogues thereof, and application thereof |
| 09/18/2013 | CN102046605B Dihydropyrazole derivatives as tyrosine kinase modulators for the treatment of tumors |
| 09/18/2013 | CN102018672B Freeze-dried liposome composition of water-soluble medicament and preparation method thereof |
| 09/18/2013 | CN102006873B Methods of modulating the activity of the mc5 receptor and treatment of conditions related to this receptor |
| 09/18/2013 | CN101926798B Dispersible tablet containing amlodipine and valsartan |
| 09/18/2013 | CN101910150B 4-benzylamino-1-carboxyacyl-piperidine derivatives as CETP inhibitors useful for the treatment of diseases such as hyperlipidemia or arteriosclerosis |
| 09/18/2013 | CN101909637B Method of determining the probability of a therapeutic response in cancer chemotherapy with cardiac glycoside |
| 09/18/2013 | CN101878199B 1,2-disubstituted-4-benzylamino-pyrrolidine derivatives as cetp inhibitors useful for the treatment of diseases such as hyperli pidemia or arteriosclerosis |
| 09/18/2013 | CN101851165B Glutamate of O-demethyl-venlafaxine and preparation method thereof |
| 09/18/2013 | CN101848717B Use of norgestimate as a selective inhibitor of trpc3, trpc6 and trpc7 ion channels |
| 09/18/2013 | CN101835780B Imidazo [1,2-alpha] pyrazine compounds for treatment of viral infections such as hepatitis |
| 09/18/2013 | CN101829120B Composition for treatment of external secretion disorders |
| 09/18/2013 | CN101825610B Method for determining related substance of otilonium bromide through high-performance liquid chromatography |
| 09/18/2013 | CN101822673B Iloperidone-containing solid medicinal composition |
| 09/18/2013 | CN101809008B Pharmaceutical composition containing optically active compound having thrombopoietin receptor agonist activity and intermediate thereof |
| 09/18/2013 | CN101756971B Oral solid drug composition of metformin hydrochloride repaglinide |
| 09/18/2013 | CN101712714B Semisynthetic trierpenoidsaponin with antitumor activity and medicinal composition thereof |
| 09/18/2013 | CN101708158B Eriocalyxin B nanosuspension and preparation method thereof |
| 09/18/2013 | CN101652383B Hepatitis c virus inhibitors |
| 09/18/2013 | CN101636388B Chemical compounds 637: pyridopyrimidinediones as pde4 inhibitors |
| 09/18/2013 | CN101541319B Na+/K+-atpase-specific peptide inhibitors/activators of Src and Src family kinases |
| 09/18/2013 | CN101535305B 5-hydroxymethyl-oxazolidin-2-one derivatives |
| 09/18/2013 | CN101511795B 1-aryl-5-alkyl pyrazole derivative compounds, processes of making and methods of using thereof |
| 09/18/2013 | CN101463061B Ginseng saponin Rg1 and Rb1 in pseudo-ginseng and preparation of total saponin thereof |
| 09/18/2013 | CN101413143B Compositions and methods for stabilizing transthyretin and inhibiting transthyretin misfolding |
| 09/18/2013 | CN101384581B Benzoyl-piperidine derivatives as 5HT2/D3 modulators |
| 09/18/2013 | CN101293831B Uses of 3-hydroxy fatty acid and its derivative in preparing calcium ion duct modifying agent |
| 09/18/2013 | CN101282742B Use of liposomes in a carrier comprising a continuous hydrophobic phase as a vehicle for cancer treatment |
| 09/18/2013 | CN101269212B Gargle capable of being swallowed |
| 09/18/2013 | CN101237851B Estrogen compositions for vaginal administration |
| 09/18/2013 | CN101155592B Method for the mitigation of symptoms of contact lens related dry eye |
| 09/17/2013 | US8536363 Compounds and methods for delivery of prostacyclin analogs |
| 09/17/2013 | US8536354 Steroidal ligands and their use in gene switch modulation |
| 09/17/2013 | US8536350 Process for the manufacture of dronedarone |
| 09/17/2013 | US8536348 Lactone formulations and method of use |
| 09/17/2013 | US8536343 Arylamidine derivative, salt thereof and antifungal agent containing those |
| 09/17/2013 | US8536342 Process for producing thiabenzoazulene-propionic acid derivative |
| 09/17/2013 | US8536338 Compounds for the treatment of hepatitis C |
| 09/17/2013 | US8536337 Solid forms of methyl (7aS,2′S)-2-(2-chlorophenyl)-2-(2,4,5,6,7,7a-hexahydrothieno[3,2-c]-5-pyridin-2-one)acetate |
| 09/17/2013 | US8536336 Prodrug compounds useful as cannabinoid ligands |
| 09/17/2013 | US8536327 Epothilone derivatives |
| 09/17/2013 | US8536325 Process for purifying guar |
| 09/17/2013 | US8536311 Inhibitor protein of the wnt signal pathway |
| 09/17/2013 | US8536229 Acetylene derivatives having MGluR 5 antagonistic activity |
| 09/17/2013 | US8536228 Transdermal compositions |
| 09/17/2013 | US8536227 Modulators of protein kinase signaling |
| 09/17/2013 | US8536226 Methods for the treatment of dermatological disorders |
| 09/17/2013 | US8536225 Therapeutic methods employing nitric oxide precursors |
| 09/17/2013 | US8536224 Pharmaceutical and nutraceutical compositions of abscisic acid |
| 09/17/2013 | US8536223 Use of PUFAs for treating skin inflammation |
| 09/17/2013 | US8536221 Amide derivatives as positive allosteric modulators and methods of use thereof |
| 09/17/2013 | US8536220 Supplement composition and method of use |
| 09/17/2013 | US8536219 Chroman-derived anti-androgens for treatment of androgen mediated disorders |
| 09/17/2013 | US8536218 Whitening agents for cellulosic substrates |
| 09/17/2013 | US8536217 Radiation curable compositions |
| 09/17/2013 | US8536216 Compositions based on aminoacids |
| 09/17/2013 | US8536214 Indane derivatives as AMPA receptor modulators |
| 09/17/2013 | US8536213 Oligomer-dantrolene conjugates and related compounds |
| 09/17/2013 | US8536211 Process for the preparation of 5-substituted 1-alkyltetrazoles |
| 09/17/2013 | US8536210 Compounds for inhibiting semicarbazide-sensitive amine oxidase (SSAO)/vascular adhesion protein-1 (VAP-1) and uses thereof for treatment and prevention of diseases |
| 09/17/2013 | US8536209 Aminotriazole derivatives as ALX agonists |
| 09/17/2013 | US8536208 Antifungal composition |
| 09/17/2013 | US8536207 Method for treating a keratoconjunctival disorder |
| 09/17/2013 | US8536206 Process for the preparation of roflumilast |
| 09/17/2013 | US8536205 Photochromic and electrochromic compounds and synthesis and use thereof |
| 09/17/2013 | US8536203 Pharmaceutical compounds |
| 09/17/2013 | US8536202 Triazole-substituted anthranilamides as pesticides |
| 09/17/2013 | US8536201 Pesticidal arylpyrrolidines |
| 09/17/2013 | US8536200 Pyridinone compounds |
| 09/17/2013 | US8536199 Oral combination of vitamins |
| 09/17/2013 | US8536198 Piperidine derivatives as modulators of chemokine receptor activity |
| 09/17/2013 | US8536197 Imidazole carbonyl compound |
| 09/17/2013 | US8536196 Substituted 1,3-dioxanes useful as PPAR modulators |
| 09/17/2013 | US8536195 Bicyclic derivatives as modulators of ion channels |